TAG:
pathology laboratory
Failure of AD Pathlabs: Structural Weakness?
By Robert Michel | From the Volume XIII No. 1 – January 16, 2006 Issue
CEO SUMMARY: AD PathLabs is the latest in a string of business disappointments. Over the past decade, a number of anatomic pathology companies have proven that they can grow rapidly—attracting substantial volumes of specimens. But these companies seem to hit a financial wall that leads …
Genomic Health, TriPath Imaging, Bio-Reference Labs, Canadian Patient Registry
By Robert Michel | From the Volume XIII No. 1 – January 16, 2006 Issue
PREDICTIVE TESTING FOR RECURRENT BREAST CANCER LABORATORY TESTS DESIGNED to predict the recurrence of breast cancer are picking up momentum. First to market was Genomic Health Inc.’s Oncotype DX™ breast cancer test. Now TriPath Imaging, Inc. is reporting…
WSJ Slams Client Bill For Lab Test Services
By Robert Michel | From the Volume XII No. 14 – October 3, 2005 Issue
CEO SUMMARY: In a front-page story last Friday, the Wall Street Journal published an investigative story on the topic of client billing for laboratory testing and anatomic pathology services. It’s a “must-read” story for all pathologists and lab managers. For years, the lab industry…
Innovative AP Reports Created by Path Group
By Robert Michel | From the Volume XII No. 12 – August 22, 2005 Issue
CEO SUMMARY: Too often local pathology groups fail to react to intensified sales competition for the biopsy referrals of clinicians in their community. In Torrance, California, the 30 pathologists of Pathology, Inc. decided it was time to invest capital and resources into developing their…
“August 22, 2005 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XII No. 12 – August 22, 2005 Issue
In California, some physicians continue to seek illegal kickbacks from clinical laboratories. The problem is widespread enough that the FBI has conducted several “sting operations.” In a jury trial related to the long-running “Durascam” healthcare fraud investigation, a married pair of doctor…
Pinkus DermPath Earns ISO-9000 Certification
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: After learning about quality management systems at a recent Executive War College, the lab director at Pinkus Dermatopathology recognized how such techniques could be used in his lab to improve quality, reduce errors, and create a better working environment for both pathologi…
Using OIG Advisory Opinions to Level Playing Field
By R. Lewis Dark | From the Volume XII No. 10 – July 11, 2005 Issue
TWICE DURING THE PAST 12 MONTHS, the Office of the Inspector General (OIG) has issued a negative opinion on a marketplace arrangement between a laboratory company and a physician group. The most recent was OIG Advisory Opinion 05-08, released on June 13, 2005 and responding to a requ…
Michel Wins Investigative Reporting Award from Peers
By Robert Michel | From the Volume XII No. 10 – July 11, 2005 Issue
IN A PRESTIGIOUS JOURNALISM CONTEST conducted by NEPA (Newsletter and Electronic Publishers Association), THE DARK REPORT’S Editor-In-Chief, Robert L. Michel, was recognized last month in the category of “best investigative reporting” for his story series on anatomic pathology …
Urology Revenue Loss Drives AP Lab Condos
By Robert Michel | From the Volume XII No. 8 – May 30, 2005 Issue
CEO SUMMARY: Urologists are motivated to operate anatomic pathology laboratory condominiums as a way to replace lost income after Medicare imposed a major reimbursement cut for a key urology procedure. Capturing revenue from ancillary services is a hot topic within the urology profession….
OIG May Be Investigating AP Laboratory Condos
By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue
CEO SUMMARY: Attorneys for one of the companies which sells and manages anatomic pathology condominium laboratories have recently sent correspondence to owners of these lab condos. This correspondence discloses that the Office of the Inspector General (OIG) is examining the company. Knowl…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized